Antiviral antibodies produced by survivors of Ebola infection continue to evolve and improve after recovery, according to a detailed study of the immune responses of four people who received care at Emory University Hospital in 2014.
* This article was originally published here
This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.
